NHS
-
Inquest opens into death of Dr. Mark Deakin, key figure in Letby trial
A formal inquest has begun into the death of Dr. Mark Deakin, a consultant paediatrician who testified during the trial of serial killer nurse Lucy Letby.
-
NHS Expands ‘Martha’s Rule’ to All Emergency Departments in England
NHS England is rolling out ‘Martha’s Rule’ to all A&E departments by 2028, allowing patients and families to trigger urgent clinical reviews of deteriorating care.
-
UK Begins First Clinical Trial Testing Alzheimer’s Drug on Healthy Adults
A new clinical trial in the UK is testing the drug Trontinemab in healthy adults aged 55-80 to see if it can prevent Alzheimer’s before symptoms emerge.
-
Channel 4 Commissions Documentary as ADHD Referrals Surge 200%
Channel 4’s new documentary investigates a 200% rise in NHS ADHD referrals, questioning if current diagnostic labels mask broader environmental struggles.
-
New Study Confirms Focal Therapy as Long-Term Effective Treatment for Prostate Cancer
A major 10-year study by Imperial College London shows focal therapy effectively treats prostate cancer with significantly fewer side effects than traditional surgery.
-
NHS Maternity Care ‘Not Fit for Purpose,’ Landmark Review Finds
A landmark inquiry led by Baroness Amos reveals systemic failures in England’s maternity services, urging urgent reforms to patient safety and accountability.
-
Largest Maternity Review in NHS History Exposes Systemic Failures at Nottingham Trust
Senior midwife Donna Ockenden has published the largest maternity inquiry in NHS history, revealing widespread failures at Nottingham University Hospitals that led to avoidable baby deaths and trauma for thousands of families.
-
Nottingham Families Demand Accountability After Inquiry Into 2023 Attacks
Families of the 2023 Nottingham attack victims have condemned a ‘catastrophic collapse of responsibility’ by state agencies as the public inquiry concludes.
-
UK National Screening Committee Recommends Against Widespread Prostate Cancer Screening
The UK National Screening Committee has advised against a national prostate cancer screening programme, citing potential harms of overdiagnosis, while recommending targeted screening only for high-risk BRCA2 carriers.
-
Streeting Shifts Focus: From NHS Reform to Foreign Policy
UK Health Secretary Wes Streeting has moved from domestic NHS industrial disputes to the international stage, issuing a sharp rebuke of President Trump’s rhetoric regarding the Iran crisis.
-
UK Blocks US Access to Bases Amid Escalating Iran Standoff
The UK government has formally refused to grant the United States access to British military bases for potential strikes against Iranian infrastructure, as tensions in the region reach a critical point.
-
Donna Ockenden Named to Lead Leeds Maternity Inquiry After U-Turn
Health Secretary Wes Streeting has appointed senior midwife Donna Ockenden to lead the maternity review at Leeds Teaching Hospitals Trust following intense pressure from affected families.
-
NHS England Misses Key Cancer Treatment Targets, Prolonging Patient Uncertainty
NHS England’s latest data for November 2025 reveals persistent failures to meet crucial cancer treatment targets, leaving thousands of patients facing prolonged waits and heightened anxiety. While the Faster Diagnosis Standard was met, the 62-day referral-to-treatment and 31-day decision-to-treat targets…
-
Amazon UK Warehouse Faces Scrutiny Amid Tuberculosis Outbreak
Amazon has confirmed an outbreak of non-contagious latent tuberculosis (TB) at its Coventry, UK fulfillment center, with 10 cases identified. The ongoing screening program has sparked criticism from unions and local politicians over worker safety.
-
Abiraterone: England Expands Access to Life-Extending Prostate Cancer Drug, Ending ‘Postcode Lottery’
Thousands of men in England with high-risk prostate cancer will now have access to the life-extending drug Abiraterone, previously limited by cost and regional disparities. This move, championed by patient advocates and charities, promises to save thousands of lives and…